Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACI.2004.11.014PMID 15696076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of montelukast compared with inhaled fluticasone on airway inflammation

  2004cited by this paper
• Safety and application of induced sputum analysis in childhood asthma.

  2004cited by this paper
• Response to montelukast among subgroups of children aged 2 to 14 years with asthma.

  2003cited by this paper
• Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.

  2003cited by this paper
• Update on glucocorticoid action and resistance.

  2003cited by this paper
• Variability and lack of predictive ability of asthma end-points in clinical trials

  2002cited by this paper
• National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002.

  2002cited by this paper
• Effects of montelukast and beclomethasone on airway function and asthma control.

  2002cited by this paper
• Pharmacogenetics of asthma.

  2002cited by this paper
• New drug treatment for asthma: clinical versus statistical significance.

  2002cited by this paper
• Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.

  2001cited by this paper
• Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.

  2001cited by this paper
• Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.

  2000cited by this paper
• A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation.

  2000cited by this paper
• Long-term effects of budesonide or nedocromil in children with asthma.

  2000cited by this paper
• Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma.

  1999cited by this paper
• Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.

  1999cited by this paper
• Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma

  1999cited by this paper
• Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children.

  1999cited by this paper
• Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.

  1998cited by this paper
• Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.

  1998cited by this paper
• Design and methods of the National Cooperative Inner‐City Asthma Study

  1997cited by this paper
• Standardization of Spirometry, 1994 Update. American Thoracic Society.

  1995cited by this paper
• Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.

  1994cited by this paper
• Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma.

  1991cited by this paper
• A concordance correlation coefficient to evaluate reproducibility.

  1989cited by this paper
• Clinical Trials: A Practical Approach

  1984cited by this paper
• Steroid Resistance in Bronchial Asthma

  1968cited by this paper
• Steroid resistance in bronchial asthma.

  1968cited by this paper
• Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services

  year unknowncited by this paper

• Asthma Phenotypes and Biomarkers

  2025cites this paper
• A multidisciplinary protocol for reducing excessive and maintaining a healthy body weight in the personalized management of chronic diseases in children and adults

  2025cites this paper
• Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation

  2025cites this paper
• GSDMB/ORMDL3 Rare/Common Variants Are Associated with Inhaled Corticosteroid Response among Children with Asthma

  2024cites this paper
• Chapter 4 Objective evaluation of asthma

  2024cites this paper
• Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study

  2024cites this paper
• Machine Learning Prediction of Treatment Response to Inhaled Corticosteroids in Asthma

  2024cites this paper
• Are single-nucleotide polymorphisms previously linked to inhaled corticosteroid response associated with obese-asthma in children?

  2024cites this paper
• Analysis of the correlation between serum Klotho and FeNO: a cross-sectional study from NHANES (2007–2012)

  2024cites this paper
• Adding Oscillometry and Fractional Exhaled Nitric Oxide to Guidelines Potentially Enhances Identification of Exacerbation Risk Factors in Asthmatic Children

  2024cites this paper
• Retrospective Analysis of Biologic Agent Utilization in Severe Asthma: Impact on Exacerbation Rates, Forced Expiratory Volume in the First Second (FEV1), Eosinophils, and IgE Levels

  2023cites this paper
• Effects of treatment with corticosteroids on human rhinovirus-induced asthma exacerbations in pediatric inpatients: a prospective observational study

  2023cites this paper
• Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases

  2023cites this paper
• IN YOUNG ASTHMATIC CHILDREN, OBESITY AND UNCONTROLLED DISEASE ARE HIGHLY ASSOCIATED WITH PERIPHERAL AIRWAY IMPAIRMENT.

  2023cites this paper
• Pharmacogenetics of childhood uncontrolled asthma

  2023cites this paper
• Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk

  2023cites this paper
• An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis

  2023cites this paper
• Biologics in the treatment of asthma in children and adolescents.

  2023cites this paper
• Smokeless tobacco enhances allergic inflammation, aggravation of asthma and oxidative stress in asthmatic patients from Algeria

  2023cites this paper
• Insights from the trends of omalizumab and mepolizumab utilization in patients with asthma: A population-based cohort study using the National Database in Japan.

  2023cites this paper
• Effectiveness of long term therapy of inhaled Steroids in Childhood Asthma: A Systemic Review

  2023cites this paper
• Best step-up treatments for children with uncontrolled asthma: a systematic review and network meta-analysis of individual participant data

  2023cites this paper
• Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, potential targeted therapy.

  2023cites this paper
• Neutrophil extracellular trap production and CCL4L2 expression influence corticosteroid response in asthma

  2023cites this paper
• Short‐acting β2‐agonist use and asthma exacerbations in Swedish children: A SABINA Junior study

  2022cites this paper
• [Update of the 2021 Recommendations for the management of and follow-up of adolescent asthmatic patients (over 12 years) under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].

  2022cites this paper
• Allergic Asthma in the Era of Personalized Medicine

  2022cites this paper
• Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplant and investigation into BOS pathogenesis.

  2022cites this paper
• Can the response to a single dose of beclomethasone dipropionate predict the outcome of long‐term treatment in childhood exercise‐induced bronchoconstriction?

  2022cites this paper
• Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian.

  2022cites this paper
• Lung Function Tests, Quality of Life and Telemedicine: Three Windows on the Multifaceted World of Asthma in Adolescents

  2022cites this paper
• IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial

  2022cites this paper
• Influence of Leukotriene Pathway Polymorphisms (Arachidonate 5-lipoxygenase ALOX5,Cysteinyl Leukotriene Receptor CysLTR1) On Response to Montelukast in A sample of Asthmatic Iraqi Patients

  2022cites this paper
• Investigational approaches for unmet need in severe asthma

  2022cites this paper
• Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8–9-Years-Old in Krakow, with High FeNO Values ≥ 20 ppb

  2022cites this paper
• Asthma Management in Children.

  2022cites this paper
• Treatment outcome clustering patterns correspond to discrete asthma phenotypes in children

  2021cites this paper
• The Montelukast Therapy in Asthmatic Children with and without Food Allergy: Does It Make Any Difference?

  2021cites this paper
• Prevention and Outpatient Treatment of Asthma Exacerbations in Children.

  2021cites this paper
• European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5–16 years

  2021cites this paper
• EstablishINg the best STEp-up treatments for children with uncontrolled asthma despite INhaled corticosteroids (EINSTEIN): protocol for a systematic review, network meta-analysis and cost-effectiveness analysis using individual participant data (IPD)

  2021cites this paper
• Pharmacogenetic Polygenic Risk Score for Bronchodilator Response in Children and Adolescents with Asthma: Proof-of-Concept

  2021cites this paper
• Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood Asthma

  2021cites this paper
• Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis

  2021cites this paper
• Sex and gender in asthma

  2021cites this paper
• Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline

  2021cites this paper
• Biomarkers to Predict Response to ICS and LAMA in Adolescents and Adults with Mild Persistent Asthma.

  2021cites this paper
• Performance of Eosinophil Cationic Protein as a Biomarker in Asthmatic Children.

  2021cites this paper
• Heterogeneity of Mild to Moderate Persistent Asthma in Children: Confirmation by Latent Class Analysis and Association With 1-Year Outcomes

  2021cites this paper
• Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.

  2021cites this paper
• Predictors of response to medications for asthma in pediatric patients: A systematic review of the literature

  2020cites this paper
• Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.

  2020influential citation
• Standardized IOS reference values define peripheral airway impairment associated uncontrolled asthma risk across ethnicity in children.

  2020cites this paper
• Fractional Exhaled Nitric Oxide and Nanomaterial Exposure in Workplaces.

  2020cites this paper
• Heterogeneity of mild-to-moderate persistent asthma in children: Confirmation by latent class analysis and association with one-year outcomes.

  2020cites this paper
• Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma

  2020cites this paper
• Pediatric Pulmonology

  2020cites this paper
• Identification of Specific IgE Antibodies and Asthma Control Interaction and Association Using Cluster Analysis in a Bulgarian Asthmatic Children Cohort

  2020cites this paper
• Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)

  2020cites this paper
• Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities

  2020cites this paper
• Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 ≥ 80% predicted.

  2020cites this paper
• Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use

  2020cites this paper
• Review of montelukast use over the past 20 years and monitoring of its effects Running title: Montelukast in wheezy children

  2020cites this paper
• Montelukast use over the past 20 years: monitoring of its effects and safety issues

  2020cites this paper
• Therapy and control of bronchial asthma in children and adolescents

  2020cites this paper
• Predicting Treatment Outcomes Using Explainable Machine Learning in Children with Asthma

  2020cites this paper
• Allergic Endotypes and Phenotypes of Asthma.

  2020cites this paper
• Sarcoidosis exosomes stimulate monocytes to produce pro-inflammatory cytokines and CCL2

  2020cites this paper
• A simple and sensitive HPLC-MS/MS assay for the quantitation of montelukast in cell-based systems in vitro pulmonary drug permeability study.

  2020cites this paper
• Defining Pediatric Asthma: Phenotypes to Endotypes and Beyond

  2020cites this paper
• Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation.

  2019cites this paper
• Role of genomics in asthma exacerbations

  2019cites this paper
• OPPORTUNITIES FOR PRECISION MEDICINE AND PRECISION PUBLIC HEALTH IN SAUDI ARABIA

  2019cites this paper
• Genomics and Pharmacogenomics of Severe Childhood Asthma

  2019cites this paper
• Atopy modifies the association between inhaled corticosteroid use and lung function decline in patients with asthma.

  2019cites this paper
• Sickle cell anemia

  2019cites this paper
• P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation.

  2019cites this paper
• GEMA (Spanish Guideline on the Management of Asthma)

  2019cites this paper
• It's Time to Start Phenotyping Our Patients with Asthma.

  2019cites this paper
• Genomic Predictors of Asthma Phenotypes and Treatment Response

  2019cites this paper
• Genome‐wide association study of inhaled corticosteroid response in admixed children with asthma

  2019cites this paper
• Severe Asthma

  2019cites this paper
• Emerging Therapies in the Treatment of Early Childhood Wheeze

  2019cites this paper
• Precision medicine in childhood asthma

  2019cites this paper
• Does understanding endotypes translate to better asthma management options for all?

  2019cites this paper
• Challenges and choices in the pharmacological treatment of non-severe pediatric asthma: A commentary for the practicing physician☆

  2019cites this paper
• Genome­wide association study of inhaled corticosteroid response in admixed children with asthma

  2019cites this paper
• Exploring the Utility of Noninvasive Type 2 Inflammatory Markers for Prediction of Severe Asthma Exacerbations in Children and Adolescents.

  2019cites this paper
• Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies.

  2019cites this paper
• Can early intervention in pediatric asthma improve long‐term outcomes? A question that needs an answer

  2019cites this paper
• Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.

  2019cites this paper
• Leukotriene‐mediated sex dimorphism in murine asthma‐like features during allergen sensitization

  2019cites this paper
• Severe asthma: mechanisms in children

  2019cites this paper
• Asthma and Corticosteroid Responses in Childhood and Adult Asthma.

  2019influential citation
• Pulmonary Function, Biomarkers, and Bronchoprovocation Testing

  2019cites this paper
• Personalized Medicine and Pediatric Asthma.

  2019cites this paper
• Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review

  2019cites this paper
• The effect of montelukast on early‐life wheezing: A randomized, double‐blinded placebo‐controlled study

  2018cites this paper
• Recognition of the peripheral airway impairment phenotype in children with well-controlled asthma.

  2018cites this paper
• The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma.

  2018cites this paper